Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

T-Ray Science Inc.

BioPhotonics
Mar 2011
In Vancouver, British Columbia, Canada, T-Ray Science Inc. has announced milestones toward the commercialization of its detection technology for skin cancer. The medical device company has signed a research agreement with the Skin Care Centre at Vancouver General Hospital and the University of British Columbia, received a Health Canada ruling that will simplify the approval process for the Verisante Aura multimodality imaging and spectroscopy system for skin cancer detection, and signed a lease for a manufacturing facility in Richmond, British Columbia. The announcements indicate progress toward bringing to market the benefits of the Aura system, which include better patient outcomes, system-wide cost savings and immediate diagnoses.

BiophotonicsBusinessCanadacommercializationdetectiondiagnosticsHealth CanadaimagingindustrialmanufacturingRapidScanskin cancerspectroscopyT-Ray ScienceUniversity of British ColumbiaVancouver General HospitalVerisante Aura

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.